The best oil for hair loss is a question many people in the UK ask when noticing increased shedding or thinning. Plant-based oils such as rosemary, peppermint, and castor oil are widely promoted, yet the clinical evidence behind them varies considerably. Before reaching for a bottle, it is important to understand what is causing your hair loss, as some conditions require prompt medical attention rather than topical remedies. This article reviews the evidence behind commonly used hair oils, explains how to use them safely, and places them in context alongside MHRA-licensed treatments and NHS guidance.

What Causes Hair Loss and When to Seek Medical Advice

Hair loss has many causes, including androgenetic alopecia, telogen effluvium, and autoimmune or systemic conditions; a GP should be consulted promptly if loss is sudden, patchy, or accompanied by scalp or systemic symptoms.

Not sure if this is normal? Chat with one of our pharmacists →

Hair loss, known medically as alopecia, is a common condition affecting both men and women in the UK. It can arise from a wide range of causes, and understanding the underlying reason is essential before considering any treatment — including topical oils. The most prevalent form is androgenetic alopecia (male- or female-pattern hair loss), which is driven by genetic sensitivity to dihydrotestosterone (DHT), a derivative of testosterone. Other common causes include:

• Telogen effluvium — a temporary shedding often triggered by stress, illness, nutritional deficiency, or hormonal changes such as postpartum shifts

• Alopecia areata — an autoimmune condition causing patchy hair loss

• Thyroid disorders, iron deficiency anaemia, or other systemic conditions

• Scalp conditions such as seborrhoeic dermatitis or tinea capitis (scalp ringworm)

• Medication-induced hair loss — a number of medicines, including retinoids, anticoagulants, antithyroid drugs, sodium valproate, and chemotherapy agents, can cause hair shedding; a medication review may be relevant

• Traction alopecia — caused by prolonged tension on the hair shaft from tight hairstyles

• Trichotillomania — a compulsive urge to pull out one's own hair

It is important to distinguish between normal hair shedding — typically 50 to 100 hairs per day — and clinically significant hair loss. You should consult your GP promptly if you notice:

• Sudden or patchy hair loss, or loss in large clumps

• Scalp symptoms such as redness, scaling, pain, or itch with loss of visible follicular openings — these may suggest a scarring alopecia (such as lichen planopilaris or folliculitis decalvans), which requires urgent dermatology referral to prevent permanent follicle loss

• Patchy scaling, 'black dot' stubble, or associated lymphadenopathy, particularly in children — these features may indicate tinea capitis, which requires prompt GP assessment and systemic antifungal treatment; topical oils should be avoided as they may worsen fungal infection

• Hair loss accompanied by fatigue, weight changes, menstrual irregularity, hirsutism, or other symptoms suggesting an underlying medical condition

A GP can arrange relevant investigations, including blood tests to check thyroid function, ferritin, and full blood count. Hormone testing (for example, androgens or prolactin) is appropriate when clinical features suggest a hormonal cause, such as menstrual irregularity or signs of hyperandrogenism in women, rather than routinely. Early assessment helps identify treatable causes and avoids delays in appropriate management. Self-treating with oils alone without ruling out an underlying condition is not advisable.

Reliable information is available through the NHS website and patient organisations such as Alopecia UK.

Evidence Behind Oils Commonly Used for Hair Loss

Rosemary oil has the strongest clinical evidence among hair oils, based on one small RCT, but no oil is NICE-endorsed or MHRA-licensed as a proven hair loss treatment.

A number of plant-based oils are widely promoted as the best oil for hair loss, though the quality and volume of clinical evidence varies considerably. It is important to approach these claims with measured expectations.

Rosemary oil is currently the most evidence-supported topical option. A small randomised controlled trial (Panahi et al., 2015; n=100, six months' duration) found that rosemary oil applied to the scalp produced comparable improvements in hair count to 2% minoxidil in participants with androgenetic alopecia. The proposed mechanisms include improving scalp microcirculation and inhibiting 5-alpha reductase — the enzyme responsible for converting testosterone to DHT — though these remain hypotheses rather than proven effects. The study was small, and larger, well-designed trials are needed before firm clinical recommendations can be made.

Peppermint oil has shown promising results in preclinical (animal) studies, with one mouse study (2014) demonstrating increased hair follicle depth and dermal thickness. Human data are currently lacking, and the evidence should be regarded as preclinical only. Peppermint oil must always be diluted in a carrier oil before use to avoid skin irritation.

Castor oil, rich in ricinoleic acid, is frequently cited anecdotally for promoting hair growth, but there is currently no robust clinical evidence supporting its use for hair loss specifically.

Coconut oil and argan oil are better supported as conditioning agents that reduce protein loss and breakage (Rele & Mohile, 2003, for coconut oil) rather than as stimulants of new growth.

Pumpkin seed oil has shown some early promise in a small randomised trial (Cho et al., 2014; n=76, 24 weeks) involving men with androgenetic alopecia, in which participants showed increased hair count compared with placebo. Importantly, this trial used oral capsules, not topical application; the evidence does not directly support scalp application of pumpkin seed oil. Long-term safety data and independent replication are lacking.

All essential oils carry a risk of allergic or irritant contact dermatitis; this should be considered before use. In summary, while some oils show early potential, none are currently endorsed by NICE or licensed by the MHRA as proven hair loss treatments.

How to Use Hair Oils Safely and Effectively

Essential oils must be diluted to 0.5–2% in a carrier oil, patch-tested for 24–48 hours before use, and applied two to three times weekly; avoid use on broken or infected skin.

If you choose to incorporate oils into your hair care routine, using them correctly can help minimise the risk of adverse effects and maximise any potential benefit. The following practical guidance applies to most topical hair oils:

Experiencing these side effects? Our pharmacists can help you navigate them →

Dilution is essential. Essential oils such as rosemary and peppermint are highly concentrated and must always be diluted in a carrier oil before scalp application. A safe dilution for scalp use is generally 0.5–2% essential oil in a carrier oil — approximately 1–3 drops of essential oil per tablespoon (15 ml) of carrier oil such as jojoba, coconut, or sweet almond oil. Applying undiluted essential oils directly to the scalp can cause contact dermatitis, chemical burns, or allergic reactions.

Patch testing before full application is strongly recommended. Apply a small amount of the diluted oil to the inner forearm and wait 24–48 hours to check for any redness, itching, or swelling before applying to the scalp.

Avoid use on broken or infected skin. Do not apply oils to areas of active scalp infection, open wounds, or inflamed skin. Keep all products away from the eyes; if accidental eye contact occurs, rinse thoroughly with water.

Application technique matters. Gently massage the diluted oil into the scalp using fingertips in circular motions for 3–5 minutes. This may help stimulate blood flow to hair follicles independently of the oil itself. Leave on for at least 30 minutes or overnight before washing out with a mild shampoo.

Frequency of use is typically two to three times per week. Overuse can lead to product build-up, which may worsen seborrhoeic dermatitis or folliculitis in susceptible individuals.

If you are also using topical minoxidil, allow several hours between applying the oil and applying minoxidil to avoid potential interference with absorption.

If a reaction occurs, discontinue use immediately and seek medical advice if you experience marked redness, swelling, blistering, or significant irritation.

Those with known allergies to plants in the Lamiaceae family (which includes rosemary and peppermint) should exercise particular caution. Essential oils are generally not recommended for use in children or during breastfeeding unless advised by a healthcare professional. Pregnant women should seek advice from a healthcare professional before using essential oils, as some carry contraindications in pregnancy.

Limitations of Hair Oils Compared to Clinically Proven Treatments

Unlike topical minoxidil and finasteride, which are MHRA-licensed with consistent clinical trial evidence, hair oils lack regulatory approval and are supported only by preliminary or preclinical data.

Whilst the search for the best oil for hair loss is understandable, it is important to contextualise these remedies against treatments with a robust evidence base and regulatory approval. In the UK, the following treatments are licensed for androgenetic alopecia:

• Topical minoxidil (available as a 2% or 5% solution or foam) — licensed by the MHRA and available over the counter from pharmacies for both men and women. It works by prolonging the anagen (growth) phase of the hair cycle and increasing follicular size. Clinical trials consistently demonstrate meaningful hair regrowth with regular use. Common adverse effects include scalp irritation and, rarely, unwanted facial hair growth. It is not generally recommended during pregnancy or breastfeeding, or in those under 18 years of age; patients should read the Patient Information Leaflet and consult a pharmacist or GP if unsure.

• Oral minoxidil is not licensed by the MHRA for hair loss in the UK. It is used off-label for this purpose under specialist supervision only, on a prescription basis. Its licensed indication is the treatment of hypertension. Cardiovascular risks and other adverse effects are relevant considerations; it should only be used under medical guidance.

• Finasteride 1 mg (oral, prescription-only for men) — a 5-alpha reductase inhibitor that reduces DHT levels, with demonstrated efficacy in clinical trials. It is prescription-only and is generally supplied via private prescription, as it is not routinely funded on the NHS for cosmetic hair loss. Important safety information includes a risk of sexual side effects (reduced libido, erectile dysfunction) and, rarely, mood changes; it is contraindicated in women of childbearing potential and during pregnancy due to the risk of harm to a male foetus. Patients should discuss risks and benefits with their prescriber and read the Patient Information Leaflet.

In contrast, no hair oil has received MHRA licensing as a medicinal product for hair loss. The evidence base for oils is largely preliminary, derived from small trials, animal studies, or observational data. This does not mean oils are without value — they may offer supportive benefits or improve scalp condition — but they should not be considered equivalent alternatives to licensed treatments.

It is also worth noting that cosmetic products (including most hair oils) are not required to demonstrate clinical efficacy in the way that licensed medicines are; advertising is regulated, but this is not equivalent to MHRA licensing for a medicinal indication. Marketing language around oils can therefore be misleading.

Patients who have not responded to lifestyle measures or who have significant hair loss should be directed towards evidence-based medical options. Combining a healthy scalp care routine with clinically proven treatments, under medical supervision, is likely to yield the best outcomes.

If you experience a suspected side effect from any medicine or healthcare product, you can report it to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

NHS and NICE Guidance on Managing Hair Loss in the UK

The NHS recommends topical minoxidil as the first-line OTC option for androgenetic alopecia, with GP referral advised for complex, scarring, or diagnostically uncertain cases.

The NHS acknowledges that hair loss is a common concern and provides guidance on when and how to seek help. For most people with gradual, patterned hair loss, an initial consultation with a GP is the appropriate first step. The GP can assess the pattern and extent of hair loss, exclude underlying medical causes through targeted investigations, and advise on suitable treatment options.

NICE does not currently have a dedicated clinical guideline specifically for androgenetic alopecia, but it does provide guidance on alopecia areata (NICE CKS: Alopecia areata). For mild cases, a watchful waiting approach is recommended, as spontaneous regrowth occurs in many patients. For more extensive or persistent cases, referral to a consultant dermatologist may be appropriate, and treatments such as topical or intralesional corticosteroids may be considered. NICE has also published a technology appraisal recommending ritlecitinib (a JAK inhibitor) as an option for some adults and young people aged 12 and over with severe alopecia areata (NICE TA926), available under specialist care where criteria are met. Patients with alopecia areata should discuss current treatment options with their GP or dermatologist.

For androgenetic alopecia, the NHS advises that:

• Topical minoxidil is the first-line over-the-counter option, available without prescription from pharmacies. It is not generally recommended in pregnancy, breastfeeding, or in those under 18 years of age.

• Finasteride 1 mg requires a prescription and is not routinely funded on the NHS for cosmetic hair loss; it is typically obtained via private prescription.

• Referral to an NHS consultant dermatologist is appropriate for complex, rapidly progressive, diagnostically uncertain, or scarring cases. Note that the title 'trichologist' is not a protected medical title and trichologists are not part of the standard NHS referral pathway; for medical assessment and treatment, a GP or NHS dermatologist is the appropriate point of contact.

It is worth noting that hair loss treatments — whether oils or licensed medicines — generally require consistent, long-term use to maintain any benefit. Stopping treatment typically results in a return to the previous rate of hair loss. Patients are encouraged to have realistic expectations and to discuss all options with their healthcare provider.

Reliable information and support are available through the NHS website (search 'hair loss'), the British Association of Dermatologists (BAD) patient information leaflets, and patient organisations such as Alopecia UK.

Frequently Asked Questions